Downregulation of LAMP2A blocks HIF-1α degradation through CMA and is sufficient to induce a TMZ-resistant phenotype in GBM sensitive cells, reducing the expression of several apoptosis-related genes upon treatment (87). The gene discussed is HIF1A; the disease is glioblastoma.